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Abstract
Two bottlenecks impeding the genetic analysis of complex traits in rodents are access to mapping 
populations able to deliver gene-level mapping resolution, and the need for population specific 
genotyping arrays and haplotype reference panels. Here we combine low coverage sequencing 
(0.15X) with a novel method to impute the ancestral haplotype space in 1,887 commercially 
available outbred mice. We mapped 156 unique quantitative trait loci for 92 phenotypes at 5% 
false discovery rate. Gene-level mapping resolution was achieved at about a fifth of loci, 
implicating Unc13c and Pgc1-alpha at loci for the quality of sleep, Adarb2 for home cage activity, 
Rtkn2 for intensity of reaction to startle, Bmp2 for wound healing, Il15 and Id2 for several T-cell 
measures and Prkca for bone mineral content. These findings have implications for diverse areas 
of mammalian biology and demonstrate how GWAS can be extended via low-coverage sequencing 
to species with highly recombinant outbred populations.
Introduction
Genome-wide association studies (GWAS) have delivered new insights into the biology and 
genetic architecture of complex traits but so far they have found application primarily in 
human genetics1,2 and in plant species where naturally-occurring inbred lines exist 3,4 . 
Two obstacles stand in the way of their routine application in other species: access to a 
mapping population able to deliver gene-level mapping resolution, and the deployment of a 
genotyping technology able to capture at least the majority of those sequence variants that 
contribute to phenotypic variation, in the absence of haplotype reference panels of the kind 
routinely employed in human populations to impute sequence variants.
In this study we exploit the properties of commercially available outbred mice for GWAS in 
the Crl:CFW(SW)-US_P08 stock. Compared to other mouse mapping populations, 
commercial outbred mice are maintained at relatively large effective population sizes and are 
descended from a relatively small number of founders, with mean minor allele frequencies 
and linkage disequilibrium (LD) resembling those found in genetically isolated human 
populations 5. Compared to a human GWAS, comparatively fewer markers are needed to tag 
the genome, thus requiring a lower significance threshold and a smaller sample size.
GWAS methodology typically uses arrays to genotype known single nucleotide 
polymorphisms (SNPs) and represents each individual’s genome as a haplotype mosaic of a 
reference panel of more densely typed or sequenced individuals (such as the 1000 Genomes 
Project 6), to impute genotypes at the majority of segregating sites in a population 7. 
However, in common with other populations that have not previously been subject to 
GWAS, commercial outbred mice lack accurate catalogs of sequence variants, allele 
frequencies and haplotypes, thus excluding the application of standard GWAS approaches.
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We show here how low coverage sequencing overcomes these limitations. We apply a 
method that models each chromosome as a mosaic of unknown ancestral haplotypes that are 
jointly estimated as part of the analysis. Using this approach we map the genetic basis of 
multiple phenotypes in almost 2000 mice, in some cases at near single-gene resolution.
Results
Phenotypes
2,049 unrelated adult Crl:CFW(SW)-US_P08 outbred mice (CFW) from Charles River, 
Portage, USA 5 were subjected to a four-week phenotyping pipeline (see Methods and 
Supplementary Figure 1). We obtained measures for 200 phenotypes from 18 assays 
(Methods). Data are available on a mean of 1,578 animals (range 905 - 1,968) per 
phenotype. We assign each measure to one of the following three heuristic categories: 
behavior, physiological or tissue; physiological measures include those taken when the mice 
were alive such as body weight and cardiac function, while the tissue measures comprise 
those obtained after dissection such as blood clinical chemistry and neurogenesis. 
Supplementary Table 1 lists the phenotypes. We tested the effect of all potential covariates 
on the variance of each measure to regress them for the genetic analysis. The strongest effect 
is batch, affecting 190 measures with a mean effect of 15%.
Genotypes
In order to capture all common variants in the CFW mice, we employed a two-stage 
genotyping strategy using low coverage sequencing that makes use of, but does not require, 
prior knowledge of segregating sites. We first generated a list of candidate variant sites using 
GATK 8 and then imputed genotype probabilities at these sites.
We obtained a mean coverage of 0.15X sequence coverage per animal for 2,073 mice (range 
0.06X to 0.51X). We identified 7,073,398 single-nucleotide polymorphisms (SNPs) in the 
~370X pile-up of all sequence data that segregated in our sample and were either 
polymorphic in laboratory strains sequenced in the mouse genomes project (MGP) (3), or 
passed GATK’s variant quality score recalibration (VQSR) (Methods). We then imputed 
genotype dosages at these sites using our reference-panel free method, STITCH (Methods, 
and Davies et al 2016). After stringent post-imputation quality control we retained 5,766,828 
high-quality imputed SNPs for subsequent analysis. Accuracy at these sites is very high: the 
mean SNP-wise correlation (r2) with 25 thousand sites polymorphic on a genotyping 
microarray9 using 44 samples was 0.974 before QC and 0.981 after QC. We annotated the 
high-quality imputed SNPs using the mouse reference mm10 assembly and identified 11,931 
SNP positions in protein coding sequence causing amino acid changes in 3,938 individual 
genes (non-synonymous substitutions) and 25,669 that do not (synonymous substitutions). 
Supplementary Table 2 categorises the variants by chromosome and Supplementary Table 3 
lists the numbers of variants obtained at each stage of the variant calling and imputation 
process.
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Genetic architecture
Inspection of the 5.7 million variants segregating in CFW mice revealed several notable 
characteristics. This total is about 1/3 fewer than the number segregating in heterogeneous 
stocks derived from classical laboratory inbred strains 10, 11,12 but far less than the 45 
million segregating in the recently created Collaborative Cross (CC) and Diversity Outbred 
(DO) populations using wild-derived strains from different subspecies of mice 11. Of the 5.7 
million imputed variants, 97.6% were found in 36 sequenced inbred strains in the Sanger 
Mouse Genomes database Release 1505. The FVB/NJ strain alone contributes 38% of CFW 
alleles (Supplementary Table 4) and in combination with the progenitors of the mouse HS13 
account for 76%. Wild-derived strains (LEWES/EiJ, ZALENDE/EiJ, WSB/EiJ, CAST/EiJ, 
MOLF/EiJ, PWK/PhJ, SPRET/EiJ) only account for about 5% of alternative alleles absent 
from other sequenced strains 11,14. Both novel and known variants have very similar minor 
allele frequency distributions across the genome (Figures 1C and 1D).
The distribution of variants across the genome is highly non-uniform (Figure 1A). 
Chromosome 16 has only 20% of the variants found on chromosome 15, despite being 
almost the same size (Supplementary Table 2). This likely reflects an extreme bottleneck in 
the founding of the CFW, a view supported by the fact that only four ancestral haplotypes 
were required for the imputation procedure to work effectively. Further, just two haplotypes 
model the majority of samples: across chromosome 19, on average, 87.1% of samples are 
represented by only two haplotypes. Rates of heterozygosity are low (Figure 1B) with 22% 
of the genome close to fixation (Figures 1A and 1C). Average minor allele frequency (MAF) 
is 0.19. Figure 1E shows the decay of linkage disequilibrium with increasing distance 
(providing an indication of the expected mapping resolution obtainable with the CFW mice). 
Average pairwise r2 falls to 0.28 at 1Mbp, 0.16 at 2 Mbp, and 0.10 at 3 Mbp.
We identified a subset of 359,559 SNPs, that tag all other SNPs with MAF >0.1% at LD 
r2>0.98. This subset was used for subsequent analyses except where stated otherwise. To 
investigate population structure and unequal relatedness between animals, we estimated 
identity by descent (IBD) from allele sharing between tagging SNPs. Supplementary Figure 
2 plots the proportion of genome with IBD = 1 against IBD = 0. For GWAS, we removed 
135 animals with higher relatedness than second-degree relatives, and 4 outliers identified 
from principal component analysis (PCA) on a genetic relatedness matrix (GRM). The 
population structure of the remaining 1934 animals was further assessed by performing 
another PCA on a GRM from only these mice. Supplementary Figure 3 plots the relationship 
between the first 5 principal components and shows no evidence of structure.
Genome-wide association
Genotypes and phenotypes were available for 1887 mice. We performed GWAS by testing 
association between the 359,559 tagging SNPs and all phenotypes. We transformed each 
phenotype by regression on relevant covariates (see Methods) and quantile-normalised the 
residuals. To test for association with SNPs on a given chromosome, we used a GRM based 
on those tagging SNPS on the other chromosomes 15,16 to increase power 17. We 
calculated a genome-wide false discovery rate (FDR) separately for each phenotype to 
determine empirical trait-specific genome-wide significance thresholds (Methods).
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At a 5% false discovery rate, we identified 255 QTLs in 92 out of 200 phenotypes (46%), as 
shown in Supplementary Table 5. Quantile-quantile plots for a representative selection of 
phenotypes are given in Supplementary Figure 4. It should be noted that due to the large 
number of SNPs used (in this case not pruned for LD) and the fact that LD extends over 
longer distances than exist in human populations, deviation from the expected values 
extends over a larger range of P-values than is commonly seen in human association studies.
Statistical power is expected to increase with MAF, and in our QTLs the MAF of 
significantly associated SNPs (range 1.7-50%, median 31%) was higher than expected 
(compared to all 5.7M SNPs) (Mann Whitney U test, P = 1.95e-28): at 133 QTLs (52%) 
MAF>30% and at only 11 (4%) is MAF <5% (Figure 2a).
To aid gene identification, we estimated the 95% confidence intervals (CI) of every QTL 
using simulations based on the LOD-drop concept18. To do so, using the imputed dosages 
around each QTL we simulated causal SNPs that matched the QTL’s observed effect size. A 
local scan of the region using the mixed model but using a simulated phenotype was 
performed, and the location and LogP of the top SNP recorded. From 1,000 simulations, we 
derived the empirical distribution of the drop (Δ) in LogP between the most highly 
associated SNP and the causal SNP (Δ is zero when the top and causal SNPs coincide). After 
ranking the simulations at a given QTL by increasing value of Δ, the LOD-drop Δ(f) of the f
% confidence interval was estimated by the maximum seen among the lowest f% 
simulations. The genomic interval spanning the LOD-drop Δ(f) determined the confidence 
interval of the QTL in the real phenotype data 18. Across all QTLs, the f = 95% CI widths 
ranged from 0.01-7.33Mb with a mean at 1.50Mb, 43% being less than 1Mb wide. On 
average each QTL covered 19 protein coding genes (0-205) with a median of 9 genes. 
Figure 2b shows the distribution of the number of genes at a QTL.
Heritability and variance attributable to QTLs
SNP-based heritability estimates exceeded 0 (at P<0.05) for 152 of 200 phenotypes, with a 
mean value of 26.3%, (range 9.1-71.1%), as reported in Supplementary Table 1. To assess 
how much of the heritability can be explained by detected QTLs (FDR<5%), we first 
estimated the effect size of each QTL by performing analysis of variance (ANOVA) at the 
most significantly associated SNP then summed the variance explained by all QTLs 
associated with every phenotype. On average, 21.1% of the heritability estimated for each 
trait with significant heritability can be explained in this way (Figure 2c). This indicates that 
missing heritability affects the CFW population, although to a lesser degree than most 
human GWAS.
Traits with higher heritabilities yielded proportionally more QTLs: the mean heritability of 
those traits for which at least one QTL was identified was 30.6%, compared to 20.6% for 
those without QTLs, a highly significant difference (t-test P-value = 8.9x10-8). Mean 
heritabilities differed between the three categories of phenotypes: 14.5% for behavior, 18.2% 
for physiological and 24.2% for tissue phenotypes. We also noted the same pattern in the 
median locus effect size of the three categories: 1.37% for behavioural QTLs, 1.5% for 
physiological and 2.8% for tissue QTLs (Figure 2c).
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Distribution of QTLs reflects genome-wide diversity
Many of the loci detected overlap, and are associated with, closely related phenotypic 
measures. Examples include the two QTLs for HDL and total cholesterol mapping over the 
Apoa2 gene on chromosome 119, or the eight different bone mineral content measures 
mapping over Slc4a2 on chromosome 520. To avoid redundancy in our analysis we 
considered that if two overlapping QTLs (where the top SNP of the first QTL lies inside the 
95% CI of the second QTL) were associated with measures of the same biological function 
they were representing a single locus. Using this approach we identified a reduced set of 156 
unique loci, each associated with 1 to 12 measures. We report these 156 unique QTLs in 
Supplementary Table 6. A “Porcupine” plot on Figure 3 shows the superimposed Manhattan 
plots of all the measures where a least one QTL was detected and highlights the 156 unique 
loci. Some regions of the genome are devoid of any QTLs, reflecting the uneven genomic 
distribution of sequence variants, a prime example being the lack of any QTL detected on 
chromosome 16 (Figure 1A). Figure 3 also highlights the presence of clusters of QTLs, 
notably on chromosomes 6, 11, 17 and X. The chromosome 17 locus overlaps the major 
histocompatibility complex (MHC), a naturally highly polymorphic region in wild 
populations that remains highly variable in the CFW mice.
Identification of candidate genes in high-resolution QTLs
We focused on those QTLs containing small numbers of genes, since these loci provide a 
starting point for functional investigations. Of the 156 unique loci identified in this study, 56 
contain three or fewer genes (36%) and 25 contain a single gene in the 95% confidence 
interval (6 QTLs do not overlap any gene).
Table 1 lists the 25 QTLs containing a single gene. The table categorizes QTLs into three 
classes, according to prior evidence supporting the candidacy of the gene at the locus. (i) 
Phenotypes of knockouts support candidacy of three genes: Met, Fli1, and Grm7. The locus 
on chromosome 6 containing the Met gene contributes to all five muscles weight measures 
(Figure 4a). Met encodes a hepatocyte growth factor receptor and has a known function in 
embryonic development 21,22 and regeneration23 of adult limb skeletal muscle. Fli1 
modulates B cells development 24 and mice lacking Grm7 are more active when placed in a 
novel environment 25 (ii) The genes at six loci are strongly corroborated by prior published 
evidence. These include the bone morphogenetic protein Bmp2 at a locus for wound healing 
26; PGC-1α, at a locus for sleep fragmentation, is involved in regulating inhibitory 
neurotransmission in the cerebral cortex associated with cortical hyperexcitability 27; a 
protein kinase (PKCα) that promotes osteoblastic cell proliferation, at a locus for bone 
mineral content 28,29; the pre B cell leukemia homeobox 1 (Pbx1) at a locus influencing 
NK cells population 30 and finally an interleukin (Il15, Fig 4d) 31 and the transcription 
factor Id2 32 at two independent loci affecting several T-cell measures. (iii) The remaining 
16 QTLs contain single genes not previously associated with the trait, including five that 
concern behaviour. Notably, our mapping results implicate Unc13c in the quality of sleep 
(Fig 4b). UNC13C is involved in synaptic transmission 33, but has never previously been 
associated with sleep. However, there is evidence for the differential expression of the 
human ortholog in individuals with poor sleep quality34. Basal home cage activity is 
associated with Adarb2, a brain-specific adenosine deaminase acting on RNA 35,36. Figure 
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4c shows that sequence variation affecting the interleukin 15 gene (Il15) is associated with 
the ratio of CD4+ to CD8+ T cells. Rtkn2, a member of the rhotekin family predominantly 
expressed in lymphoid cells 37, influences intensity of reaction to startle (Fig 4d). CNVs for 
the human orthologue of Rtkn2 have been implicated in attention-deficit and hyperactivity 
disorder38.
Discussion
Genome-wide association mapping for complex traits has been used extensively in human 
populations but less commonly in other organisms. We have shown here that mapping using 
commercially available outbred mice can identify individual genes involved in complex 
traits, some of which cannot easily be assayed in human subjects. Our results raise issues 
about the nature of mouse resources for mapping complex traits, and about the biological 
insights that can thereby be attained.
Several resources have been developed to provide GWAS tools to rodent genetics. These 
resources fall into two broad categories: (i) genetic reference populations, consisting of pre-
existing inbred strains (Hybrid Mouse Diversity Panel, HMDP 12) or recombinant inbred 
strains (BxD39 and Collaborative Cross40), (ii) populations descended after multiple 
generations of pseudo-random breeding from inbred strains (diversity outcross (DO) mice 
41 and heterogeneous stocks (HS)13). Each resource differs in its utility for GWAS, and no 
single population is ideal 1.
Commercially available outbred mice are an alternative resource with a number of 
advantages, and the CFW stock has already been used to map skull shape QTLs 42. 
Compared to HMDP and HS animals, there was minimal evidence for population structure, 
and standard GWAS methods developed for human populations can be applied. LD decays 
fast enough to provide gene-level mapping resolution at about a fifth of loci, and although 
the resolution is still lower than in human populations, it is better than other mouse 
resources. The size of QTLs varied considerably, with the largest ones extending over 
several megabases, but half contained fewer than 10 genes, providing a relatively small list 
to investigate the biology at these sites.
Compared to other rodent mapping resources, our results also indicate that the CFW 
population delivers fewer loci for fewer phenotypes. We mapped loci for 92 out of 200 traits 
included in our phenotyping pipeline, yielding a mean number of 1.3 QTLs per trait, in 
1,887 mice. One possible explanation for the low yield of QTLs is that the amount of genetic 
variation present in the CFW stock is relatively limited. Indeed, almost a quarter of the CFW 
genome is virtually devoid of variants. For comparison, the 5.7M variants in the CFW is less 
than the 7.2M segregating in the rat heterogeneous stock 10. However, a more important 
determinant for QTL detection in the CFW is likely to be allele frequencies (p), which are 
on average lower in the CFW than in the HS. Since the variance explained by a QTL is 
proportional to p(1 – p), effect sizes, and hence power, are systematically smaller in the 
CFW. Indeed, the median effect size is 1.6%, which, while dwarfing the effects found to 
underlie human quantitative traits, is still less than half that found in the rat HS (median 
estimate 5%) 10.
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The inclusion of a large number of behavioural measures in our pipeline also contributed to 
the relatively low QTL detection rate. Almost a third of the traits (63/200) were collected 
from behavioral tests, yet the QTLs mapped with these measures accounted for less than 
14% of the total. These phenotypes typically had lower heritabilities, with fully one quarter 
(16) having no significant genetic contribution. Note that these non-significant estimates (as 
well as those for non-behavioural phenotypes) do not necessarily mean the traits are not 
heritable: the standard errors on these estimates are large (Supplementary Table 1), so that 
no heritability less than 10% can be reliably estimated. Those loci we did detect had 
relatively lower effect sizes (mean for behavioural QTLs was 1.37, compared to 1.5 for 
physiological and 2.8 for tissue QTLs).
The heritability of the behavioural measures might also have been affected by the fact that 
mice were repeatedly tested over a 4 weeks period. Most behaviors are sensitive to repeated 
handling and exposure to different types of novel stimuli, as will happen during the 
extensive phenotypic battery deployed here. Habituation to these exposures makes it harder 
to detect alleles that affect baseline differences in behavior, especially anxiety-like behaviors 
for which three different assays were conducted over a relatively short time frame. A more 
focused assessment of a specific behavioral phenotype under tightly controlled 
environmental conditions could have yielded higher heritabilities for some traits.
These observations lead to two conclusions. First, finding more QTLs in the CFW will 
require thousands of mice. Supplementary Table 7 gives the power to detect QTLs in the 
CFW population as a function of effect size and sample size. For a typical QTL 
corresponding to the median effect size (1.6%) and sample size (1,732) in the current study, 
power is about 80% at a genome-wide significance level of 10%. Power falls off for smaller 
effects sizes: a 0.5% QTL is detectable with 6.6% power with 1,732 animals; increasing the 
sample size to 4,000 increases the power to 51%, and with 6,000 it is 85%. However, 
“winner’s curse” means that the true effects are likely to be lower than reported here, and 
given that our QTLs explain only 20% of the heritability it is reasonable to assume that the 
majority of loci will have effect sizes less than 1%. Second, additional loci can be found 
using different stocks. Not all commercial outbred mice populations are the same, as we 
previously documented in a survey of 66 stocks in which mean heterozygosity varied from 
0.5% to 45% and mean minor allele frequencies from 0.03% to 0.5%5. The use of 
complementary populations will make additional alleles open to discovery.
Our study is the first to use extremely low coverage sequence to generate accurate genotypes 
without a reference panel. This strategy, and the associated STITCH algorithm43, is 
generally applicable to any population, and any species, for which there is no information 
about segregating variation or haplotypes. It is competitive with arrays in terms of cost, 
although the optimal choice of strategy will depend on the reagents available for the 
population in question. An advantage of sequencing over array-based genotyping is that it 
does not require prior information about which variants are segregating in a population; nor 
does it require a pre-existing catalogue of variants or prior knowledge of the likely founders 
of the population. The only requirement is a high-quality reference genome.
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One unexpected finding was that, only 25,000 SNPs in the standard megaMUGA mouse 
genotyping array are polymorphic in the CFW mice; many of the QTLs we mapped would 
likely have been overlooked by genotyping with this array. The CFW mice appear to be 
descended from four ancestral haplotypes, indicating this population was likely bottle-
necked to two founding individuals. Our population is effectively biallelic at most loci, and 
there was little to be gained by considering haplotype-based tests of association (data not 
shown).
We could also test associations at candidate variants responsible for the effect. For example, 
the Met gene on chromosome 6 is associated with muscle phenotypes and our sequence data 
revealed two missense variants: I851M and R968C. The first variant is common amongst 
mouse strains and is not known to alter gene function. The second variant, confirmed by 
Sanger sequencing, is specific to the SWR/J strain44. The human homolog (R988C) has 
been identified in two small cell lung cancer cell-lines and increases constitutive tyrosine 
phosphorylation activity in vitro 45. The R968C missense variant is associated with the five 
muscle weight phenotypes but the direction of the effect of the alternative allele is positive in 
extensor digitorum longus (EDL) and gastrocnemius and negative in the others. This 
difference reflects differences in the muscle fiber composition (soleus is dominated by type 
1 and 2A fibers, EDL is enriched in 2X and 2B fibers 46) suggesting that R968C affects 
these fibers differently or shifts the composition in all muscles.
We have shown here how low-cost commercially available outbred mice can deliver novel 
biological insights. We found single genes at 16 loci where no prior evidence existed for 
their involvement (Table 1). Importantly, the loci include those from phenotypes that could 
not easily be assayed in human subjects, such as response to hypoxia and the sleep 
phenotypes. More than 50 QTLs contain documented candidate genes (Supplementary Table 
5): Slc4a2, which leads to osteopetrosis when disrupted in mice 20, is present at a QTL 
affecting bone mineral content; Apoa2 and Scarb1, both known to affect blood lipid 
homeostasis 19,47 are detected at two distinct QTLs for cholesterol levels; Gdnf, a gene 
required for the neuronal colonization of the pancreas, at a locus for pancreatic amylase 48. 
These examples demonstrate that the narrow QTLs detected in CFW mice can lead to the 
identification of the genes affecting the measured traits, emphasizing the potential of our 
results as a resource to identify new genes in those QTLs without documented candidates.
Online Methods
Study animals and phenotyping
A total of 2117 outbred mice (Crl:CFW(SW)-US_P08, 1065 males and 1052 females) were 
purchased from Charles River, Portage, USA at 4-7 weeks of age over a period of 2 years. 
Animals were selected from the breeding colony as to avoid siblings and half-siblings. 
Monthly shipments of approximately 130 mice were delivered, maintained and tested at the 
MRC Harwell in Harwell, Oxfordshire, UK following local regulations. Mice of the same 
age within each shipment were treated as a batch (approximately 30 animals, range 7 to 36, 
half males and half females, the total number of batch for the entire study is 69) and each 
animal randomly assigned a testing order. Mice were housed in IVC cages (3 per cage) on an 
ad lib diet for the duration of the study. At 16 weeks of age 2049 mice started a 4-weeks 
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phenotyping pipeline in which we collected behavioral and physiological data (Suppl. Fig. 1 
and full description of the phenotypes measured in the Supplementary Note). Mice within a 
batch performed each test during the same day following the assigned testing order. The 
sequencing of the animals was performed after completion of the study so experimenters 
were blind to the genotype of the mice during testing. Power calculations to estimate the 
sample size for the mapping experiment assumed effect sizes were similar to those identified 
in a previous analysis of outbred stocks 5. Every effort was made to minimize suffering by 
considerate housing and husbandry. All phenotyping procedures were examined for potential 
refinements. All animal work was carried out in accordance with UK Home Office 
regulations. The project was reviewed by the ethics committee at MRC-Harwell: Animal 
Welfare and Ethical Review Board, approval license PPL 30/2653.
Pre-processing of Phenotype Data
Analysis of the phenotypic data was performed using the R statistical analysis software 50. 
Outliers, defined as observations more than 3 standard deviations from the mean, were 
excluded. The effect of covariates such as sex and batch on quantitative phenotypes were 
assessed with analysis of variance (ANOVA) and those explaining more than 1% of the 
variance at P<0.05 were included in a multiple linear regression model from which residual 
measures were obtained. Batch, defined here as mice of the same age in each individual 
shipment, was treated as a random effect. All tests with covariates and models used to 
generate the residuals for genetic mapping are shown in Supplementary Table 1. We then 
quantile-normalised the residuals to minimize the effects of non-normality.
Sequencing
Genomic DNA was extracted from tissue samples of 2,028 mice that began the pipeline 
using Nucleon BACC resin (Hologic) following the manufacturer’s instructions. DNA was 
obtained from an additional 45 mice from the same population where no phenotypic 
measures were available producing a total of 2073 samples for analysis. Each individual 
DNA sample was then sonicated and barcoded with an in house unique 8-mer 
oligonucleotide 51. Groups of 95 barcoded DNA samples were pooled and pair end 100bp 
sequenced on 1 lane Hi-Seq generating read groups of ~30 Gb sequence per lane/pool.
Alignment to mm10 reference and pre-processing of sequence data
BWA version 0.5.6 52 was used to align the reads from each read group to the mouse mm10 
reference genome. The BWA alignments were refined with Stampy v1.0.21 53 and 
converted into the bam format by samtools v0.1.18-dev54. Library PCR duplicates were 
removed with samtools and sequence reads processed following the pipeline described 
11,14. All bam files were processed through the Indel Realignment and Base Quality Score 
Recalibration steps of the Genome Analysis Toolkit (GATK) 8 recommended Best Practices 
55. All pre-processing used GATK v2.4-9-g532efad. The option –rf BadCigar was applied to 
filter out reads that a) have hard/soft clips in the middle of the CIGAR string, b) start or end 
in deletions, c) fully hard/soft clipped, d) have consecutive INDELs in them. The option –rf 
BadMate was applied to filter out reads whose mate maps to a different contig. Previously 
discovered INDELs from all mouse strains in the Mouse Genome Project (MGP) 11,56 were 
used as intervals for Indel Realignment in addition to those discovered in the 2073 mice, and 
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SNPs from the Mus musculus domesticus strains in MGP were used as known sites masked 
for Base Quality Score Recalibration.
Variant calling from low coverage sequencing data
Variant calling was then performed using all 2073 bam files with GATK’s Unifed Genotyper 
with thresholds -stand_call_conf 30 and -stand_emit_conf 30, as well as options for building 
variant quality recalibration tables: -A QualByDepth -A HaplotypeScore -A 
BaseQualityRankSumTest -A ReadPosRankSumTest -A MappingQualityRankSumTest -A 
RMSMappingQuality -A DepthOfCoverage -A FisherStrand -A HardyWeinberg -A 
HomopolymerRun.
Raw vcf files from variant calling step for all chromosomes except chromosome Y were 
pooled together for variant quality score recalibration (VQSR) using GATK’s 
VariantRecalibrator under SNP mode. Training, known and true sets for building the positive 
model are the SNPs which segregate among the classical laboratory strains of the Mouse 
Genomes Project 11 (2011 release REL-1211) on all chromosomes except chromosome Y. 
Transversion ratios (TsTv) and recalibration tables were generated at 14 sensitivities (100.0, 
99.9, 99.0, 97.0, 95.0, 90.0, 85.0, 80.0, 75.0, 70.0, 65.0, 60.0, 55.0, 50.0) to training sets for 
runs of VQSR utilizing different sets of annotations. A final set of annotations for VQSR 
and sensitivities to known sites were chosen to maximize TsTv at both known and novel 
sites to reduce the rate of false positive calls. Sensitivity of 97% for known sites was selected 
for a total of 8,597,879 SNPs (6,430,809 known and 2,177,070 novel, TsTv of 2.13 at 
known sites and 1.56 at novel sites). We then further removed sites that were fixed 
alternative allele variants (hence non-polymorphic in our study) or were multi-allelic, 
leaving 7,073,398 (5,701,865 known, 1,371,533 novel, TsTv of 2.13 at known sites and 1.56 
at novel sites) biallelic SNPs. The annotations used for VQSR were HaplotypeScore, 
BaseQualityRankSumTest, ReadPosRankSumTest, MappingQualityRankSumTest, 
RMSMappingQuality, DepthOfCoverage, FisherStrand, HardyWeinberg, HomopolymerRun.
We used the 7M biallelic SNPs in the mice cohort for imputation, using the method 
described below. To ensure quality of the imputed of SNPs used for downstream genetic 
analysis, we first extracted those SNPs imputed with high certainty using IMPUTE2-style 
INFO scores. We observed from inspecting allele distributions that an INFO score greater 
than 0.4 indicated markers where the three genotype classes were clearly separable. Thus we 
included only sites that met this criterion. We also discarded sites where more than 10% of 
mice had maximum genotype probability smaller than 0.9, and on autosomal chromosomes 
we discarded sites where the P-value for violation of Hardy Weinberg equilibrium was 
smaller than 10-6. This resulted in a final set of 5.76M SNPs that we used for genetic 
mapping. Lastly, we used the most current release of the Sanger mouse genomes database 
(2016, REL-1505, comprising 36 genomes, almost twice the original number) to refine the 
set of novel SNPs. The number of novel sites among the 5.76M dropped from 799,133 
(13.8%) to 152,671 (2.6%) (Supplemental Table S3). However, the TsTv ratios for the novel 
SNPs remained little changed, at 1.74 and 1.73 respectively.
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Imputation
We developed a novel imputation algorithm, STITCH, described in a separate publication 
(Davies et al). This employed a hidden Markov model (HMM) that extended the population 
genetic methods of Li and Stephens57, and more specifically the fastPHASE algorithm of 
Scheet and Stephens 58. We assume that the CFW population was founded with K unknown 
ancestral haplotypes and that the chromosomes of each sequenced CFW mice are mosaics of 
the founder haplotypes. After some experimentation with different values of K we found that 
K=4 was optimal (ie the population was modeled as being founded from two individuals).
Simulating under the model (hidden ancestral states and sequencing reads) consists of: (i) 
choosing initial state probabilities (πk) from one of the k haplotypes (ii) choosing where to 
recombine between ancestral haplotypes assuming G=100 of generations since the 
population’s founding and a genetic distance between SNPs t and t+1 (σt) (iii) choosing the 
ancestry within each segment with respect to the frequencies of each founder haplotype at 
that location (αt,k), and (iv) sampling read locations, base qualities, underlying unobserved 
bases and observed sequenced bases, based on the relative probability that ancestral 
haplotype k emits a reference or ancestral base at SNP t (θt,k). Together, these represent the 
parameters of the model λ = (π, σ, α, θ).
To generate the probabilistic genotype of an individual CFW outbred mouse, we first 
calculate the probability of observing a given sequencing read given membership in 
ancestral haplotype k, as follows. We first removed SNPs with low base quality (<17) and 
SNPs in reads with low mapping quality (<17). For an individual read Rr indexed by r, let Jr 
be the number of SNPs in the read and P(sr,j | gi = i) = ϕir,j the base-quality scaled emission 
probability of sequencing read sr,j given true underlying genotype i. Let SNP j in read Rr 
correspond to SNP ur,j. We assume the probability of a recombination within a read is low, 
so we assign each read as having been emitted from a central SNP t=cr. Therefore, the 
probability of read Rr given it came from ancestral haplotype k is
and the probability of observing all reads at SNP t in a diploid sample given diploid hidden 
state at SNP t of qt = (k1, k2) is
The full chromosome diploid probability is then calculated using the initial, recombination 
and transition probabilities in the normal manner.
We ran the method for 40 Expectation-Maximisation (EM) iterations, where in each 
iteration, during the expectation step, state probabilities are calculated for each mouse using 
the current parameters of the model, while in the maximization step, new initial, transition, 
recombination and emission parameters are estimated based on state probabilities. Upon 
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completion, haplotype and genotype probabilities, as well as dosages, are calculated. For 
example, the dosage of the number of Alt alleles is 1* P(G = (Ref,Alt) / O, λ) + 2* 
P(G=(Alt,Alt) / O, λ) for a given mouse and SNP site.
Selection of tagging SNPs
We then identified a subset of 359,559 (353,697 autosomal) tagging SNPs with MAF > 
0.1% and LD r2< 0.98. Genotypes at these sites were called based on maximum genotype 
probability from imputation; genotypes were only called based on maximum genotype 
probabilities of higher than 0.9, mice with maximum genotype probability of smaller than 
0.9 at a particular site would have a missing genotype at the site.
Sample selection based on estimation of Identity by Descent (IBD) between samples
Pairwise Identity by Descent (IBD) was estimated by calculation of pairwise Identity by 
State (IBS) using PLINK (v1.07) at the tagging SNPs located on the autosomal 
chromosomes. Mice were excluded from further analysis if they had estimated PIHAT of 
higher than 0.5 with at least one other mice, or percentage IBS=1 of higher than 0.75 with at 
least one other mice, or percentage of IBS=0 of smaller than 0.25 with at least one other 
mice. 135 mice were excluded by the above criteria.
Sample Selection based on Principal Component Analysis (PCA)
Linkage Disequilibrium Adjusted Kinship (LDAK, version 5.9) 59 was used to estimate 
local linkage disequilibrium (LD) by calculation of local pairwise correlations between 
SNPs and generating weightings of each SNP in the calculation of a genetic relatedness 
matrix (GRM) adjusted for local LD. The GRM was generated using hard-called genotypes 
at the tagging SNPs of MAF > 5% from all autosomes. Principal component analysis (PCA) 
was performed on the GRM to derive the top 20 principal components (PCs). PC2 separates 
out four mice from the rest; these four mice were excluded from further analysis.
Estimation of whole-genome SNP-based heritability
LDAK (version 5.9) was used to generate a new GRM using hard-called genoytpes of MAF 
> 5% at the same tagging SNPs in mice remaining in the analysis. Restricted maximum 
likelihood (REML) was used to estimate h2 of each of the 200 phenotypes measured.
QTL mapping
We mapped quantitative trait loci (QTLs) at the tagging SNPs using purpose-written 
software in R. For each phenotype k, we used the quantile-normalised residuals yk for QTL 
mapping and heritability analysis. Although we found little evidence of unequal degrees of 
relatedness between the CFW mice, as a precaution we used mixed models to control for 
cryptic relatedness and to avoid false positive QTL calls. We first used the imputed dosages 
of the tagging SNPs on the autosomal chromosomes to compute genome wide kinship 
matrices (K). Thus, if aip is the imputed reference allele dosage of SNP p in individual i then 
the genetic relationship Kij between individuals i,j is defined to be the Pearson correlation 
coefficient of the vectors aip, ajp across all autosomal tagging SNPs p. The i,j ‘th element of 
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the population-wide genetic relationship matrix K is Kij. We also computed leave-one-out 
kinship matrices Kc for each chromosome c, using all tagging SNPs not on chromosome c.
We modified the standard mixed model formulation for mapping QTLs by computing 
separate mixed models for each chromosome, in order to ameliorate the reduction in 
statistical significance of a locus caused by the same information being present in the 
kinship matrix. To test association between the phenotype k and tagging SNP p resident on 
chromosome, we estimated the phenotypic covariance matrix  where the 
genetic and environmental variance components  are estimated as above, and 
factorized it into its square root using the eigen-decomposition
where Ekc is the orthogonal matrix of eigenvectors and Λkc the diagonal matrix of 
eigenvalues of Vkc. Then we fitted the transformed mixed model
where µ, α are parameters to be estimated, and the error vector e is uncorrelated so the 
model can be fit efficiently by computing the correlation coefficient of 
Nominal statistical significance at a locus was measured as the logP (the negative log10 of 
the P-value of the ANOVA comparing the fit of the allele model to the null model). We 
defined a candidate QTL as any locus such that the logP was at a local maximum compared 
to the tests at neighbouring loci, and no other locus within 3Mb had a larger logP.
We estimated separate genome-wide thresholds for each phenotype, aiming to control the 
per-phenotype false discovery rate (FDR). We made Q = 100 permutations of each 
transformed phenotype vector Zkc, keeping the transformed allele dosages fixed, and refitted 
the model. This is efficient because most of the computational effort in fitting a mixed model 
is reusable when fitting the permuted phenotypes. We found candidate QTLs in the 
permuted data in the same way and estimated the per-phenotype FDR of a QTL as
where Nk(x), Pk(x) are the numbers of QTLs with logP ≥ x observed for phenotypek in the 
unpermuted and permuted data respectively, and Q = 100 is the number of permutations. 
Custom R code for QTL mapping, written specifically for this project, is available from 
R.M.
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Fine mapping
Once a QTL had been mapped using the tagging SNPs and exceeded the FDR threshold, 
association was re-calculated with all imputed SNPs (from the 5.7M set) in a 20Mb window 
around the peak using the same mixed model.
Confidence Interval Estimation
Confidence intervals were estimated by simulation. First, at each QTL, a residual phenotype 
was constructed by removing the effect of the top SNP at the QTL from the phenotype 
vector used in the QTL mapping above. This ablated the QTL whilst maintaining genetic 
contributions from elsewhere in the genome. Next, 1000 SNPs were selected at random, 
subject to the constraint that they were within 2.5Mb of the top SNP and were polymorphic 
in the subset of individuals phenotyped for the trait (where the 95% interval estimate was 2.0 
Mb or greater, we repeated the analysis using SNPs up to 10Mb from the top SNP). A causal 
variant was simulated at the SNP, with effect size matching that of the top SNP, taking 
account of the allele frequency, and its trait value added to the residual phenotype. A local 
scan of the region using the same mixed model but the simulated phenotype was performed 
and the location and logP of the top SNP recorded. Across the 1000 simulations, we 
estimated the distribution of the drop Δ in logP between the simulated top SNP and the 
simulated causal SNP (this was zero when the top and causal SNPs coincided). We used the 
fraction of simulations f(Δ) within Δ to determine confidence intervals for the original 
phenotype data. Thus we identified the range of SNPs within 2.5Mb of the top SNP and with 
a logP drop less than Δ to define the 100f(Δ)% confidence interval for the QTL. We did this 
using both the tagging SNPs and the fine-mapping SNPs.
Power Calculation
Since we applied an FDR approach to call QTLs we did not require a logP threshold that 
would be required in order to determine power. However, in order to estimate power and the 
effects of sample size and effect size, we determined approximate genome-wide thresholds 
based on permutations of the mixed-model transformed phenotypes z = A−1y keeping the 
genotypes fixed in order to preserve LD structure. For each of the 200 phenotypes, we 
performed 100 permutations and computed the genome-wide maximum logP across the 
359,559 tagging SNPs in order to define genome-wide thresholds T(p) at p = 0.5,0.1,0.5 
levels of significance (e.g. the threshold T(p) is such that in a fraction p of simulations the 
genomewide maximum logP exceeds T(p). Thresholds vary slightly between phenotypes, so 
we used the thresholds obtained by pooling all 20,000 simulations to estimate power for 
sample sizes N = 1000,1732,2000,4000 and apparent effect sizes v = 0.01,0.016,0.02. (N = 
1732 and v = 0.016 are the median sample size and effect size in the current study). Power 
π(N,v,T) to detect a QTL with effect size and sample size at genome-wide logP threshold T, 
was computed as  where  is the noncentral chi-
square distribution on 1df with noncentrality parameter Nv, and w(T) is the quantile of a 
standard chi-squared distribution corresponding to logP T, ie 
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Sequence diversity of the CFW population. (a) Distribution of heterozygosity in 100kbp 
windows genome-wide. (b) Histogram of genome-wide heterozygosity. (c) Example of 
novel and total SNP density for a region of chromosome 19. Results are representative of 
those seen genome-wide. (d) Minor allele frequency (MAF) density for population of wild 
Indian (n=10, 44.9 M whole genome sequencing SNPs), CFW mice (n=2,073, 5.7M imputed 
SNPs) and HS mice (n=1,904, 11K SNPs from a genotyping array). Known CFW variation 
refers to those variants also segregating among 14 sequenced classical inbred strains. (e) The 
extent of linkage disequilibrium in CFW and HS mice. Values are mean r2 between all pairs 
of SNPs binned by distance to the kbp.
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Figure 2. 
Mapping resolution and effect size of QTLs. Frequency distribution of (a) the size and (b) 
the number of genes present in the 95% confidence intervals (CI) in 255 QTLs, (c) The sum 
of variance explained by the QTLs plotted against heritability in 92 measures where 
heritability could be estimated and at least one QTL was detected. Colour of dots indicates 
the type of measure: behaviour, physiological (body weight, respiratory, 
electrocardiography) or tissue (any measure obtained after dissection)
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Figure 3. 
Summary Manhattan plot of 92 phenotypes. Genome-wide representation of all unique 
QTLs (n=156, FDR<5%) identified in this study. Light and dark grey dots show association 
from the 92 measures where at least one QTL was detected at the tagging SNPs positions 
(n=359,559). Most significant SNPs at each QTL are marked with a colour dot, depending 
on the type of measure. Y-axis shows –log10(P) of the imputed allele dosages with tested 
measures and is truncated at –log10(P)=32. The position of the 2 strongest QTLs with –
log10(P) values of 133 (chr4) and 76 (chr17) is marked by triangles.
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Figure 4. 
Single-gene resolution mapping at 4 loci using the entire set of SNPs (7.1 M). (a) Weight of 
soleus muscle on chromosome 6 (n=1832), (b) Measure of the number of long sleep 
episodes on chromosome 9 (n=1577), (c) Ratio of CD4+ to CD8+ T cells (CD3+) on 
chromosome 8 (n=1324) and (d) Intensity of reaction to startle on chromosome 10 
(n=1740). The plots were drawn using LocusZoom 49. Strongest associated SNP is marked 
with a purple diamond, the other SNPs that passed post-imputation quality control 
(IMPUTE2-style INFO scores > 0.4 and HWE r2>1e-6,) are coloured following LD r2 with 
strongest SNP. The grey dots represent SNPs that failed post-imputation QC and therefore 
were not used for the analysis.
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Table 1
QTLs mapping to a single gene
Phenotype Chr. Position (Mb) -logP Gene References
Knock-out mouse recapitulates the phenotype
Weight of soleus muscle (g) 6 17.5 16.2 Met 21–23
Total distance travelled in Elevated Plus Maze (cm) 6 110.2 5.6 Grm7 25
CD45+/CD3-/CD19+ cells (%) 9 32.6 5.8 Fli1 24
Association supported by literature
CD45+/CD3-/DX5+ cells (%) 1 168.2 4.7 Pbx1 30
Wound healing 2 134.2 5.5 Bmp2 26
Number of long (>1min) sleep episodes 5 51.8 6.8 Ppargc1a 27
Ratio of CD3+/CD4+ to CD3+/CD8+ cells 8 82.4 8.7 Il15 31
Bone mineral content 11 108.2 4.6 Prkca 28,29
CD3+/CD8+ cells (%) 12 25.5 5.4 Id2 32
No previous evidence
Length of tibia (mm) 5 51.7 4.5 Ppargc1a
Startle pulse reactivity 6 17.5 6.7 Met
Calcium (mmol/l) 6 17.5 8.3 Met
Total Cholesterol (mmol/l) 6 17.5 6.1 Met
Total Protein (g/l) 6 17.5 27.7 Met
CD45+/CD3-/CD19+ cells (%) 7 72.2 6.2 Mctp2
Number of long (>1min) sleep episodes 9 73.8 5.5 Unc13c
Startle pulse reactivity 10 68.0 8.0 Rtkn2
Weight of tibialis anterior muscle (g) 11 17.6 6.3 Etaa1
Length of tibia (mm) 12 83.6 7.1 Zfyve1
Basal activity 13 7.3 10.6 Adarb2
Respiratory rate during Hypoxic Ventilatory Decline 13 118.0 5.9 Hcn1
Total distance travelled in Elevated Plus Maze (cm) 14 82.1 6.2 Pcdh17
Measure of the size of tibia 15 26.6 5.3 Fbxl7
Percentage of Eosinophils (%) 17 70.4 5.2 Dlgap1
Percentage of Eosinophils (%) X 155.6 6.0 Ptchd1
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